Magnesio Solfato S.A.L.F.

Magnesium sulfate, the active ingredient in Magnesio Solfato S.A.L.F., is a magnesium salt presented as a sterile aqueous solution for intramuscular and intravenous use. It is employed to correct magnesium deficiency and to manage specific obstetric, cardiac and respiratory emergencies in hospitalized patients.

GNH USA supplies Magnesio Solfato S.A.L.F. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The product meets European Union quality standards and is manufactured under GMP conditions, ensuring consistent potency and sterility for clinical use. It is available for bulk purchase and can be integrated into hospital formularies.

Magnesium sulfate is used to treat conditions related to magnesium deficiency and acute obstetric or cardiac emergencies. - Magnesium deficiency: restores serum magnesium levels and prevents neuromuscular irritability. - Preeclampsia/eclampsia: prevents seizures by stabilizing neuronal excitability in pregnant patients. - Torsades de pointes: terminates ventricular arrhythmias by correcting electrolyte imbalance. - Severe asthma exacerbations: provides bronchodilation through calcium antagonism in refractory cases.

Magnesium sulfate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Flushing or warmth at the injection site. - Nausea or mild gastrointestinal discomfort. - Headache or dizziness. - Transient hypotension.

Serious or Rare Side Effects: - Severe hypotension leading to shock. - Respiratory depression or arrest. - Hypermagnesemia causing cardiac arrhythmia or cardiac arrest. - Anaphylactic reaction with rash, bronchospasm, or angioedema.

Magnesium sulfate requires careful monitoring in several clinical situations. - Renal impairment: monitor serum magnesium and adjust dosing. - Cardiac disease: use cautiously in patients with conduction abnormalities. - Neuromuscular disorders: avoid rapid bolus in myasthenia gravis. - Pregnancy: safety not established; weigh benefits versus risks. - Drug interactions: review concomitant calcium channel blockers and neuromuscular blockers. - Store below 25°C: keep in original container, protect from moisture and light.

Magnesium sulfate can interact with several drug classes, requiring vigilance.

Major Interactions (Avoid): - Calcium channel blockers: additive vasodilatory effect may cause severe hypotension. - Neuromuscular blocking agents: enhanced blockade can lead to respiratory failure. - Other magnesium-containing products: risk of hypermagnesemia.

Moderate Interactions (Monitor Closely): - Loop diuretics: increase renal magnesium loss, may require dose adjustment. - Aminoglycoside antibiotics: may heighten neuromuscular weakness. - ACE inhibitors or ARBs: can augment hypermagnesemia in patients with renal impairment.